Covaxin Phase 3 Results Show 81% Efficiency, says Bharath Biotech
Saturday, February 4, 2023
  • Circulation
  • Advertise
  • About Us
  • Contact Us
Organiser
  • ‌
  • Bharat
  • World
  • G20
  • Editorial
  • Analysis
  • Opinion
  • Sports
  • More
    • Defence
    • RSS in News
    • Azadi Ka Amrit Mahotsav
    • My States
    • Vocal4Local
    • Business
    • Special Report
    • Culture
    • Sci & Tech
    • Entertainment
    • Education
    • Books
    • Interviews
    • Travel
    • Health
    • Obituary
SUBSCRIBE
No Result
View All Result
  • ‌
  • Bharat
  • World
  • G20
  • Editorial
  • Analysis
  • Opinion
  • Sports
  • More
    • Defence
    • RSS in News
    • Azadi Ka Amrit Mahotsav
    • My States
    • Vocal4Local
    • Business
    • Special Report
    • Culture
    • Sci & Tech
    • Entertainment
    • Education
    • Books
    • Interviews
    • Travel
    • Health
    • Obituary
No Result
View All Result
Organiser
No Result
View All Result
  • Home
  • Bharat
  • World
  • G20
  • Editorial
  • Opinion
  • Analysis
  • Culture
  • Defence
  • RSS in News
  • My States
  • Vocal4Local
  • Subscribe
Home Bharat

Covaxin Phase 3 Results Show 81% Efficiency, says Bharath Biotech

WEB DESK by WEB DESK
Mar 4, 2021, 11:22 am IST
in Bharat
Share on FacebookShare on TwitterTelegramEmail

After a third round of clinical trials, Bharat Biotech on March 3 announced that its Covaxin vaccine was 81 percent effective in preventing COVID-19. Covaxin showed 81 percent interim efficacy in preventing COVID-19 in those without prior infection after the second dose, the company said.

“Data from 25,800 participants received a vaccine or placebo in a 1:1 ratio showed that the vaccine candidate was well tolerated,” the company said in a statement.

The first interim analysis is based on 43 cases, of which 36 cases of COVID-19 were observed in the placebo group versus 7 cases observed in the Covaxin group, resulting in a point estimate of vaccine efficacy of 80.6 percent.
Covaxin is developed by Bharat Biotech in collaboration with the Indian Council of Medical Research and the National Institute of Virology.

The vaccine has been approved for restricted emergency use under clinical trial mode. The vaccine will have to be taken in two doses with 28 days apart.

ShareTweetSendShareSend
Previous News

‘Never aimed for power or position’, VK Sasikala Announces Retirement from Politics Ahead of TN Assembly Election

Next News

Indulged in anti-national activities, Guwahati Press Club shown the door

Related News

Chhattisgarh: After more than a decade and a half the Maoist menace is fading away in Jagargunda

Chhattisgarh: After more than a decade and a half the Maoist menace is fading away in Jagargunda

Quad to focus on tackling Chinese threat in telecom, 6G technology

Quad to focus on tackling Chinese threat in telecom, 6G technology

Jammu & Kashmir Har Gaon Hariyali – A stepping stone to bigger success

Jammu & Kashmir Har Gaon Hariyali – A stepping stone to bigger success

Shaligram Stone: A new bridge to stregthen Bharat-Nepal Civilisational bonds

Shaligram Stone: A new bridge to stregthen Bharat-Nepal Civilisational bonds

Defence Budget 2023: A move towards Atmanirbharta and improving security environment

Defence Budget 2023: A move towards Atmanirbharta and improving security environment

PFI WhatsApp group for mediapersons

PFI WhatsApp group for mediapersons

Comments

The comments posted here/below/in the given space are not on behalf of Organiser. The person posting the comment will be in sole ownership of its responsibility. According to the central government's IT rules, obscene or offensive statement made against a person, religion, community or nation is a punishable offense, and legal action would be taken against people who indulge in such activities.

Latest News

Chhattisgarh: After more than a decade and a half the Maoist menace is fading away in Jagargunda

Chhattisgarh: After more than a decade and a half the Maoist menace is fading away in Jagargunda

Quad to focus on tackling Chinese threat in telecom, 6G technology

Quad to focus on tackling Chinese threat in telecom, 6G technology

Jammu & Kashmir Har Gaon Hariyali – A stepping stone to bigger success

Jammu & Kashmir Har Gaon Hariyali – A stepping stone to bigger success

Shaligram Stone: A new bridge to stregthen Bharat-Nepal Civilisational bonds

Shaligram Stone: A new bridge to stregthen Bharat-Nepal Civilisational bonds

Defence Budget 2023: A move towards Atmanirbharta and improving security environment

Defence Budget 2023: A move towards Atmanirbharta and improving security environment

PFI WhatsApp group for mediapersons

PFI WhatsApp group for mediapersons

Assam drive against child marriage: Over 2044 men arrested in crackdown against child marriage; 4004 cases registered

Assam drive against child marriage: Over 2044 men arrested in crackdown against child marriage; 4004 cases registered

Budget 2023: A pragmatic budget to bridge the gap between rural and urban India

Budget 2023: A pragmatic budget to bridge the gap between rural and urban India

Parliament Budget Session: Amid ruckus on Adani row, both houses of Parliament adjourned

Parliament Budget Session: Amid ruckus on Adani row, both houses of Parliament adjourned

BSF troops shoot down Pakistan drone in Punjab’s Amritsar sector, recover contraband

BSF troops shoot down Pakistan drone in Punjab’s Amritsar sector, recover contraband

  • Privacy
  • Terms
  • Cookie Policy
  • Refund and Cancellation
  • Delivery and Shipping

© Bharat Prakashan (Delhi) Limited.
Tech-enabled by Ananthapuri Technologies

No Result
View All Result
  • Home
  • Bharat
  • World
  • Editorial
  • Analysis
  • Opinion
  • Defence
  • Culture
  • Sports
  • Business
  • RSS in News
  • My States
  • Vocal4Local
  • Special Report
  • Sci & Tech
  • Entertainment
  • Education
  • Books
  • Interviews
  • Travel
  • Health
  • Obituary
  • Subscribe
  • Advertise
  • Circulation
  • About Us
  • Contact Us
  • Privacy Policy
  • Cookie Policy
  • Terms of Use
  • Refund and Cancellation

© Bharat Prakashan (Delhi) Limited.
Tech-enabled by Ananthapuri Technologies